Recurrent lacunar ischaemic stroke due to resistance to antiplatelet treatment: examining the need for personalised antithrombotic therapy
Neurologia. 2015 Jul-Aug;30(6):376-8.
doi: 10.1016/j.nrl.2013.09.001.
Epub 2013 Dec 11.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Neurología, Hospital Universitario Central de Asturias, Oviedo, España. Electronic address: mglezdelgado@yahoo.es.
- 2 Servicio de Hematología, Hospital Universitario Central de Asturias, Oviedo, España.
- 3 Servicio de Radiología, Hospital Universitario Central de Asturias, Oviedo, España.
- 4 Servicio de Neurología, Hospital Universitario Central de Asturias, Oviedo, España.
No abstract available
MeSH terms
-
Brain Ischemia
-
Cilostazol
-
Clopidogrel
-
Drug Resistance
-
Female
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Middle Aged
-
Platelet Aggregation Inhibitors / therapeutic use*
-
Precision Medicine
-
Recurrence
-
Risk Factors
-
Stroke, Lacunar / drug therapy*
-
Tetrazoles / therapeutic use
-
Ticlopidine / analogs & derivatives*
-
Ticlopidine / therapeutic use
Substances
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors
-
Tetrazoles
-
Clopidogrel
-
Cilostazol
-
Ticlopidine